Table 1 Patient characteristics.
| Diagnosis | Patients (n) | Median | F:M ratio | Median | Blood basophils |
|---|---|---|---|---|---|
| age (y) | WBC (× 109/l) | (median %) | |||
| CML (all) | 46 | 57.5 | 1:2.1 | 110 | 5 |
| CML‐CP | 37 | 57 | 1:2.1 | 103.5 | 4 |
| CML‐AP | 9 | 58 | 1:2 | 258.4 | 18 |
| PV | 20 | 66.5 | 1:1.2 | 10.05 | 1 |
| ET | 20 | 58 | 1:1 | 9.5 | 2 |
| CIMF | 20 | 71 | 1:1.2 | 11.35 | 1 |
| ISM | 7 | 41 | 1:0.75 | 6.8 | 0 |
AP, accelerated phase; CIMF, chronic idiopathic myelofibrosis; CML, chronic myeloid leukaemia; CP, chronic phase; ET, essential thrombocythaemia; ISM, indolent systemic mastocytosis, PV, polycythaemia vera; y, years.